Chapter 11 references
1. The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. International Ophthalmology Clinics, 1987; 27(4): 239–53.
2. Meyers SM. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy. American Journal of Ophthalmology, 1980: 90(2): 210–6.
3. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina, 1985: 5(1): 5–10.
4. Ferris FL 3rd, Podgor MJ, Davis MD. Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12. Ophthalmology, 1987; 94(7): 754–60.
5. Lee CM, Olk RJ, Akduman L. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy. Ophthalmic Surgery and Lasers, 2000; 31(4): 292–300.
6. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology, 1991; 98(5 Suppl): 766–85.
7. Hamilton A, Ulbig M, Polkinghorne P. Management of Diabetic Retinopathy. 1996; London: BMJ Publishing Group.
8. Arevalo JF, WuL, Sanchez JG, et al. Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye, 2007; 23(1): 117–23.
9. Jorge R, Costa RA, Calucci D, et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina, 2006; 26(9): 1006–13.
10. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology, 2006; 113(10): 1695e1–15.
11. Mason JO 3rd, Nixon PA, White MF, Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. American Journal of Ophthalmol, 2006; 142(4): 685–8.
12. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina, 2006; 26(3): 275–8.
13. Adamis AP, Altaweel A, Bressler NM, et al.. Changes in retinal neovascularisation after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology, 2006; 113(1): 23–8.
14. Bressler SB, Qin H, Melia M, et al. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmology, 2013; 131(8): 1033–40.